Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta Cell Allografts in Type 1 Diabetes
NCT00798785Phase 2Unknown
- Sponsor
- AstraZeneca
- Start
- Oct 2006
- Primary completion
- Dec 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab, basiliximab in type 1 diabetes mellitus (T1D), sponsored by AstraZeneca. Status: unknown.
02
Drugs
rituximabbasiliximab
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00798785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00798785.